{'fraction_non_alphanumeric': 0.046251993620414676, 'fraction_numerical': 0.030303030303030304, 'mean_word_length': 4.20746887966805, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Limits in the applicability of urine delta aminolevulinic acid determination as a screening test in the evaluation of occupational lead poisoning].

The relationship between concentrations of ALA-U and Pb-S for two groups of workers is reported. The first group consisted of workers from a telephone company, and the second, of workers from battery factories with average Pb-S equivalent to 17.3 (g/dl (6.2-39.4) and 61.5 (g/dl (41.1-91.0), respectively. The aim of this study was to evaluate the utilization of ALA-U levels as a screening test for different levels of lead in blood by means of High Performance Liquid Chromatography (HPLC) and of spectrophotometry. A significant correlation was found between measured ALA and levels of blood lead (R = 0.739 - first group; R = 0.902 - second group; p < 0.001). The validity of ALA-U test to evaluate different levels of lead in blood was also studied. By using ALA levels of 3mg/g creatinine as a threshold to detect levels of lead in blood equal to or higher than 20 (g/dl, the test results, for the workers in the first group, showed sensibility of 92% and specificity of 90%. In both groups, the false positives as well the false negatives were lower than 10% which was enough to validate the test.